9th Annual Biomarkers Congress

Drug Design: National Institutes of Health

Total Score People Score Events Score
112 97 44
Date Event Presentation Speakers
June 4, 2013 World Pharma Congress Organs-on-Chips for Predicting Drug Toxicity and Efficacy Danilo Tagle
April 3, 2011 Evolving Approaches to Early Stage Drug Discovery (Z2) Probe Development within the Molecular Libraries Probe Production Centers Network (MLPCN): Leads for Drug Development from Previously Intractable Targets Linda Brady
February 6, 2011 5th Drug Discovery for Neurodegeneration: An Intensive Course for Translating Research into Drugs Basics of High Throughput Screening (HTS) J Inglese
Basics of High Throughput Screening (HTS) J Inglese
January 13, 2011 Second Annual Membrane Proteins Preparation of Stable Isotope-Labeled GPCR by Bacterial Fermentation Alexei Yeliseev
August 23, 2010 The Ubiquitin Drug Discovery & Diagnostics Conference Structural Insights and Functional Complexity of E2 - RING Finger E3 Interactions Allan Weissman
May 20, 2010 Bioanalytical Challenges for Optimizing Protein Therapeutics The Mesothelin-CA125/MUC16 Interaction Mitchell Ho
April 28, 2010 Kinase Inhibitor Chemistry Targeting the Polo-Box Domain of Polo-Like Knase 1 (Plk1) Kyung S Lee
February 22, 2010 2010 PERSONALIZED MEDICINE PARTNERSHIPS CONFERENCE Alternative Partnering Models for Personalized Medicine Christopher Austin
October 6, 2009 Third Annual Improving Protein Expression Through Innovation Preparation of Stable Isotope-Labeled Cannabinoid Receptor CB2 for NMR Structural Studies Alexei Yeliseev
September 24, 2009 Track 4: Bridging Silos in Biomarker Development : Seventh Annual Protein Biomarkers Towards a More Efficient Protein Biomarker Development Process Henry Rodriguez
September 23, 2009 Track 3: Advancing Cancer Therapy : Second Annual Translational Cancer Medicine Targeting Tumor Microenvironment Suresh Mohla
August 18, 2009 Second Annual Pre-Clinical/Clinical Development of Immunotherapies and Vaccines Behavioral and Social Science Considerations for Clinical Research Chuen-Yen Lau
August 5, 2009 Drug Safety Strategies to De-Risk Compounds Leveraging Resources to Advance Drug Development: A Consortium Model for Biomarkers Research Shawnmarie Mayrand-Chung
May 11, 2009 Patient Recruitment in Clinical Trials Informed Consent, Informed Decision, and the Good Recruitment Practice Initiative Linda Wolff
The Importance of Standardizing Study Coordinator Training: Essential Elements April Bower
April 7, 2009 Inaugural HIV Inhibitors Featured Presentation: Reverse Transcriptase-Associated Ribonuclease H Activity as a Therapeutic Target Stuart F.J. Le Grice
February 8, 2009 CHEMISTRY IN CANCER RESEARCH: A Vital Partnership in Cancer Drug Discovery and Development Session 9: Chemistry in Support of Cancer Drug Discovery and Development I David A. Wink, Jr, Murali Krishna
January 26, 2009 Translational Cancer Medicine BETTER in vivo MODELS : Mouse Cancer Models in Translation: Past, Present and Future Glenn Merlino
January 5, 2009 High Content Analysis Multiparametric Flow Cytometry Analysis of Immune Responses for Vaccine Development Mario Roederer
Application of Quantitative High-Throughput Screening to High-Content Analysis of Cell-Based Assays Sunita J Shukla
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Identification of Novel Modifier Genes of Sox10 Neurocristopathy by a Functional Genomic approach : Track 1-3 Ling Hou
Application of Advanced Technologies to Personalized Oncology: Track 1-7 Francis S Collins
Biological Comparison of Human Anti-AMA1 IgGs :Track 2-9 Kazutoyo Miura
Development of Lentiviral Vectors for Studying on Gene Function, Gene Discovery and Gene Therapy :Track 2-12 Zhennan , Lai
September 29, 2008 Genomic Biomarkers Biomarkers for What? Diagnostic, Prognostic or Predictive? Sudhir Srivastava
September 29, 2008 Metabolic Biomarkers Biomarkers for What? Diagnostic, Prognostic or Predictive? Sudhir Srivastava
July 19, 2008 22nd Annual Symposium of The Protein Society Concurrent Afternoon Symposia 8: Membrane Proteases Susan Buchanan
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Faculty James Doroshow, Giuseppe Giaccone
Panel Discussion Jeffrey S Abrams
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
cancer genetics-- Neurofibromatosis Type 1: The Development and Treatment of Neural Tumors Brigitte C. Widemann
clinical trials-- The End of P Values? Why Alternative Methods to Making Inferences May Be Superior Steven Hirschfeld
developmental therapeutics-- DNA Repair Modulators Yves Pommier
genitourinary cancer-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
lymphoma and plasma cell disorders-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
patient and survivor care-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
patient and survivor care-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
pediatric cancer-- Neurofibromatosis Type 1: The Development and Treatment of Neural Tumors Brigitte C. Widemann
special sessions-- Opening Ceremony with Presidential Address, NCI Director’s Address, The ASCO Cancer Foundation Donor Appreciation Awards, and Karnofsky Memorial Award Lecture John E. Niederhuber
tumor biology-- Molecular and Pharmacokinetic Aspects of Brain Metastases (M04) Patricia Steeg
meet the professor sessions-- Molecular and Pharmacokinetic Aspects of Brain Metastases (M04) Patricia Steeg
meet the professor sessions-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
March 30, 2008 Metabolic Pathways of Longevity Workshop 1: Drug Discovery/Therapeutic Intervention Nancy L Nadon
March 30, 2008 Nuclear Receptors: Steroid Sisters Workshop 1 - Hot Topics Hong Soon Kang
Steroid Receptor Signaling and Dynamics Gordon L. Hager
Steroid Receptors and Chromatin Trevor K. Archer
Workshop 2 - Hot Topics: Repression/Regulation of Nuclear Receptor Function Ian Adcock
Workshop 3 - Hot Topics: Chromatin/Transcription Trevor K. Archer
Steroid Receptor Biology Kenneth S. Korach
March 30, 2008 Nuclear Receptors: Orphan Brothers Workshop 1 - Hot Topics Hong Soon Kang
Steroid Receptor Signaling and Dynamics Gordon L. Hager
Steroid Receptors and Chromatin Trevor K. Archer
Workshop 2 - Hot Topics: Repression/Regulation of Nuclear Receptor Function Ian Adcock
Workshop 3 - Hot Topics: Chromatin/Transcription Trevor K. Archer
Steroid Receptor Biology Kenneth S. Korach
March 25, 2008 Preclinical Development Imaging as a Biomarker in Oncology Drug Trials and Improving Cancer Patient Care Gary J. Kelloff
March 25, 2008 TRANSLATIONAL MEDICINE The Challenges of Biomarker Validation in the Clinical Setting Stephen M Hewitt
Expression of Genes and microRNAs as Biomarkers of Hematopoietic Stem Cell Potency David Stroncek
RNA Amplification as an Essential Approach for Biomarker Discovery Ena Wang
Imaging as a Biomarker in Oncology Drug Trials and Improving Cancer Patient Care Gary J. Kelloff
March 25, 2008 CYTOKINE-BASED THERAPEUTICS CNS Inflammatory Diseases Charles E Egwuagu
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic SESSION A: GRANT WRITING AND INTERNATIONAL FUNDING SOURCES Suresh Mohla
Grant Writing and Funding Opportunities at the NCI Suresh Mohla
A Rose between Two Thorns: Selecting the Right Journal Margaret A. Tucker
Title to be announced Michael Birrer
Molecular Profiling of Cancer: Challenges and Opportunities Paul Meltzer
The Promise of Genome-wide Association Studies Margaret A. Tucker
February 19, 2008 ADMET Europe Quantitative High-Throughput Screening for Cell-Based Toxicity Assays Menghang Xia
February 17, 2008 GRC - Peptides, Chemistry & Biology Of Peptide Structure Prediction: Energetics and Conformational Searching Peter J. Steinbach
December 1, 2007 47TH American Socieity of Cell Biology Membrane Dynamics Jennifer Lippincott-Schwartz
The C-terminal Extension of hCenexin1 Is Critical for Proper Recruitment and Mitotic Functions of Mammalian Polo-like L. Yu, T. Veenstra
Adhesions and Myosins (Room 204 A/B) Robert S Adelstein
Cell Matrix Interactions (Room 140A) Kenneth. M. Yamada
Advances in Bone Cell Molecular Biology: Epigenetic Control Michael Bustin, Gordon L. Hager
Cellular Biology of Gap Junction Channels (Room 103A) Richard Francis
High Performance Image Analysis and Photomanipulative Techniques for Gordon L. Hager
Dynamics of Rafts, Stabilized Rafts, and Other Non-Raft Domains of Jennifer Lippincott-Schwartz
The NCI Alliance for Nanotechnology in Cancer: Creating Next Piotr Grodzinski
Seeing in The Dark: How Fluorescent Proteins Are Shaping Biology Jennifer Lippincott-Schwartz
Lamin A-dependent Misregulation of Adult Stem Cells Associated with Accelerated Aging. T Misteli
The Arf1 GAP Centaurin Gamma-2/AGAP1 Modulates Neuronal Differentiation. P Randazzo
VEGF Controls Endothelial Cell Permeability by the Endocytosis of VE-cadherin J. Silvio Gutkind,
Understanding the Cell Migration Engine Using High-Resolution Quantitative Light Microscopy Clare M Waterman
A Molecular Mechanism for Aging-related Loss of Heterochromatin and DNA Damage. G Pegoraro, T Misteli
NSBP1: A Novel Protein Which Binds Specifi cally to Nucleosome in Euchromatin and Affects Cellular Differentiation. M Rochman, Michael Bustin
Global Interactions of the Glucocorticoid Receptor Require Extensive Chromatin Remodeling. M Sung, S. John, T A Johnson, P S Meltzer, J Stamatoyannopoulos, Gordon L. Hager
Supported by Merck Research Laboratories:RNA Silencing Mechanisms Natasha J Caplen
Applications of RNAi Screens in the Study of Cancer-associated Processes John N Weinstein, Natasha J Caplen, K Huppi
Intercellular Transfer as a Mechanism of Cell Communication within the Hematopoietic Progenitor Niche. Jennifer M Gillette, Jennifer Lippincott-Schwartz
Role of Mitochondrial Remodeling in Programmed Cell Death in Drosophila melanogaster Richard Youle, B Fell
G1 to S Phase Cell Cycle Progression Requires a Single Electrically-coupled Mitochondrial Network with a Continuous Kasturi Mitra, Jennifer Lippincott-Schwartz
Analysis of Myosin II-induced Maturation of Focal Adhesions. Clare M Waterman
Vesicular Traffi cking and Protein Synthesis Are Required for Streaming during Chemotaxis Carole A Parent, Guofeng Zhang, Paul W Kriebel, Valarie A Barr
Mechanisms of Membrane Traffi cking Juan S Bonifacino
The Complexity of Phosphorylated H2AX Foci and DNA Repair Protein Assembly at DNA Double-stranded Breaks William M Bonner
Structural Analysis of Dynamin Family Members Offers Insight into Membrane Fission Jason A Mears
The AP4 Complex Mediates Sorting of the Amyloid Precursor Protein at the trans-Golgi Network Juan S Bonifacino
Actin Dynamics Regulate a Biophysical Maturation Switch in Focal Adhesions. Clare M Waterman
Effects of O-GlcNAcase on Insulin Signaling in Adipocytes D. Love
November 29, 2007 Fourth Annual In Vivo Molecular Imaging: Bridging the Gap from Discovery to Clinical Applications Nov (29-30) Imaging Tools - Novel Developments (08:25-13:40) Jacek Capala
Imaging Tools - Novel Developments: A New Molecular Tracer for In Vivo Monitoring of HER2 Expression by Positron Emission Tomography (08:30-09:00) Jacek Capala
Clinical Applications (13:40-17:30) Hisataka Kobayashi
Clinical Applications: Multiplexing Probes for in vivo Molecular Imaging (14:15-14:45) Hisataka Kobayashi
November 15, 2007 Second Annual Drug Development India : Planning and Managing Drug Discovery & Development Activities Nov(15-16) PRECLINICAL DEVELOPMENT AND CHALLENGES: CO-PRESENTATION : Overcoming the Regulatory Environment Hurdles in Setting up Vivarium and In Vivo Drug Discovery Resource (16:00-16:30) Suresh Poosala
PRECLINICAL DEVELOPMENT AND CHALLENGES (15:30-18:45) Suresh Poosala
November 4, 2007 AACR Centennial Conference: Translational Cancer Medicine Plenary Session 3: Animal Systems and Imaging in Cancer Research Huynh HUNG
Plenary Session 4: New Trials and Genomic-based Design James H. DOROSHOW
Plenary Session 6: Clinical Intervention and Populations Outcomes: Global Strategies Douglas R LOWY
October 17, 2007 Inaugral Nuclear Harmone Receptors Modulators: Targets for Drug Discovery Oct (17-18) NUCLEAR HORMONE RECEPTORS (14:10-18:50) John Cidlowski
NUCLEAR HORMONE RECEPTORS: Glucocorticoid Receptors: Old Targets that Need New Drugs (14:45-15:15) John Cidlowski
DISCOVERY CHEMISTRY (08:35-12:55) William T. Schrader
DISCOVERY CHEMISTRY: Chairperson’s Remarks (08:35-08:40) William T. Schrader
INNOVATIVE TECHNOLOGIES FOR NHR MODULATORS (13:55-17:10) William T. Schrader
INNOVATIVE TECHNOLOGIES FOR NHR MODULATORS: Chairperson’s Remarks (13:55-14:00) William T. Schrader
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) RNAi Targets and Cancer Biology: Applications of RNAi Screens in the Study of Cancer-associated Processes (11:40-12:10) Natasha J Caplen
October 15, 2007 2nd Annual Innovations in Clinical Trials: Implementations of Biomarkers (Oct15-16) Colorectal Adenomas: A Prototype for the Use of Surrogate End Points in the Development of Cancer Prevention Drugs (10:00-10:30) Gary J. Kelloff
ADDRESSING THE VALIDATION BOTTLENECK (Featured Speaker) Proteomic Technologies for Cancer Research: A Strategic Plan for Translating Discoveries to the Clinic (11:15-11:45) Henry Rodriguez
ADDRESSING THE VALIDATION BOTTLENECK (11:10-13:25) Henry Rodriguez
October 11, 2007 Compound Profiling & Chemogenomic Approaches to Drive Decision Making and Predict Clinical Adverse Effects (Oct 11-12) SCREENING AGAINST MULTIPLE TARGETS (Shared Session with Drug Repositioning Summit) (12:30-17:15) Jill Heemskerk
SCREENING AGAINST MULTIPLE TARGETS: Ceftriaxone and Results of Large Scale Screening Efforts (16:15-16:45) Jill Heemskerk
October 10, 2007 Drug Repositioning Summit: Finding New routes to success (Oct 10-11) SCREENING AGAINST MULTIPLE TARGETS (Shared Session with Compound Profiling) (13:30-17:15) Jill Heemskerk
SCREENING AGAINST MULTIPLE TARGETS: Ceftriaxone and Results of Large Scale Screening Efforts (16:15-16:45) Jill Heemskerk
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Third annual Genomic Biomarkers: BIOMARKER DATA ANALYSIS: Decipher and Select the Genomic Biomarkers with the DAVID Bioinformatics Resources (17:30-18:00) Richard A. Lempicki
Third annual Genomic Biomarkers: BIOMARKER DATA ANALYSIS (16:00-18:00) Richard A. Lempicki, Brian Luke
Third annual Genomic Biomarkers: BIOMARKER DATA ANALYSIS: Comparing Fingerprint-based and Biomarker-based Classifiers (16:00-16:30) Brian Luke
Fifth Annual Protein Biomarkers; BIOMARKER DATA ANALYSIS: Comparing Fingerprint-based and Biomarker-based Classifiers (16:00-16:30) Brian Luke
Fifth Annual Protein Biomarkers; BIOMARKER DATA ANALYSIS (16:00-18:00) Richard A. Lempicki, Brian Luke
Fifth Annual Protein Biomarkers; BIOMARKER DATA ANALYSIS: Decipher and Select the Genomic Biomarkers with the DAVID Bioinformatics Resources (17:30-18:00) Richard A. Lempicki
September 10, 2007 Drug Development In China: Strategies for launching Discovery and Development activities Current State of In Vivo Tox and Path Contract Research in China (10:30-11:00) Suresh Poosala
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.